LGT Group Foundation’s Edwards Lifesciences EW Stock Holding History

LGT Group Foundation’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.12M	Buy	45,592 +3,600	+9%	+$302K	0.05%	134
2026 Q1	$3.36M	Sell	41,992 -4,078	-9%	-$336K	0.04%	135
2025 Q4	$3.97M	Sell	46,070 -2,104	-4%	-$173K	0.04%	141
2025 Q3	$3.68M	Sell	48,174 -3,007	-6%	-$235K	0.04%	151
2025 Q2	$4M	Sell	51,181 -5,188	-9%	-$387K	0.05%	142
2025 Q1	$4.09M	Sell	56,369 -2,152	-4%	-$154K	0.06%	147
2024 Q4	$4.33M	Buy	58,521 +13,370	+30%	+$936K	0.07%	142
2024 Q3	$2.94M	Buy	+45,151	New	+$3.28M	0.05%	166
2022 Q2	–	Sell	-2,577	Closed	-$317K	–	271
2022 Q1	$317K	Sell	2,577 -6,043	-70%	-$678K	0.01%	243
2021 Q4	$1.12M	Buy	+8,620	New	+$1.01M	0.03%	202

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

LGT Group Foundation's EW Position: Q2 2026 in Review

LGT Group Foundation increased its Edwards Lifesciences (EW) stake by 8.6% in Q2 2026, buying an estimated $302K and bringing the position to 45,592 shares worth $4.12M. The position accounts for 0.05% of the portfolio, ranked #134.

LGT Group Foundation first reported a position in EW in Q4 2021 and has held it in 10 quarters since. The position peaked at $4.33M in Q4 2024. 833 funds tracked by Wall St. Rank hold EW as of Q2 2026.

LGT Group Foundation held 45,592 shares of Edwards Lifesciences worth $4.12M as of Q2 2026.
LGT Group Foundation bought 3,600 Edwards Lifesciences shares in Q2 2026, an estimated $302K.
Edwards Lifesciences made up 0.05% of LGT Group Foundation's portfolio in Q2 2026, its #134 holding.
LGT Group Foundation first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 10 quarters since.
LGT Group Foundation's Edwards Lifesciences position peaked at $4.33M in Q4 2024.
833 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.